img

Post-pandemic Era-Global RNA-Based Vaccines Market 2015-2034, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin


Published on: 2024-01-04 | No of Pages : 121 | Industry : Medical Devices & Consumables Research Center

Publisher : X | Format : PDF

Post-pandemic Era-Global RNA-Based Vaccines Market 2015-2034, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Summary

World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

MRAResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This research report indicated that the global RNA-Based Vaccines market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of RNA-Based Vaccines Market by MRAResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in RNA-Based Vaccines Market?
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
...
Major Type of RNA-Based Vaccines Covered in MRAResearch report
Type I
Type II
Application Segments Covered in MRAResearch Market
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global RNA-Based Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Type I -Product Introduction and Major Manufacturers
1.1.2 Type II -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China RNA-Based Vaccines Status and Prospect (2015-2026)
2.1.1 China RNA-Based Vaccines Market Size and Growth Rate (2015-2026)
2.1.2 China RNA-Based Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU RNA-Based Vaccines Status and Prospect (2015-2026)
2.2.1 EU RNA-Based Vaccines Market Size and Growth Rate (2015-2026)
2.2.2 EU RNA-Based Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA RNA-Based Vaccines Status and Prospect (2015-2026)
2.3.1 USA RNA-Based Vaccines Market Size and Growth Rate (2015-2026)
2.3.2 USA RNA-Based Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan RNA-Based Vaccines Status and Prospect (2015-2026)
2.4.1 Japan RNA-Based Vaccines Market Size and Growth Rate (2015-2026)
2.4.2 Japan RNA-Based Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India RNA-Based Vaccines Status and Prospect (2015-2026)
2.5.1 India RNA-Based Vaccines Market Size and Growth Rate (2015-2026)
2.5.2 India RNA-Based Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia RNA-Based Vaccines Status and Prospect (2015-2026)
2.6.1 Southeast Asia RNA-Based Vaccines Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia RNA-Based Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America RNA-Based Vaccines Status and Prospect (2015-2026)
2.7.1 South America RNA-Based Vaccines Market Size and Growth Rate (2015-2026)
2.7.2 South America RNA-Based Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 RNA-Based Vaccines Status and Prospect (2015-2026)
2.8.1 RNA-Based Vaccines Market Size and Growth Rate (2015-2026)
2.8.2 RNA-Based Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global RNA-Based Vaccines Market Assessment by Segment
3.1 Global RNA-Based Vaccines Capacity and Growth Rate
3.2 Global RNA-Based Vaccines Sales by Type
3.3 Global RNA-Based Vaccines Sales Revenue by Type
3.4 Global RNA-Based Vaccines Consumption by Application
4 Global RNA-Based Vaccines Market Assessment by Regions
4.1 Global RNA-Based Vaccines Production Analysis and Forecast by Regions (2015-2026)
4.2 Global RNA-Based Vaccines Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global RNA-Based Vaccines Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 RNA-Based Vaccines Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on RNA-Based Vaccines Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global RNA-Based Vaccines Capacity Market Share of Manufacturers (2019-2020)
6.2 Global RNA-Based Vaccines Sales Market Share of Manufacturers (2019-2020)
6.3 Global RNA-Based Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)

7 RNA-Based Vaccines Competitive Analysis
7.1 Pfizer
7.1.1 Pfizer Company Profiles
7.1.2 Pfizer Product Introduction
7.1.3 Pfizer RNA-Based Vaccines Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Roche
7.2.1 Roche Company Profiles
7.2.2 Roche Product Introduction
7.2.3 Roche RNA-Based Vaccines Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Profiles
7.3.2 Sanofi-Aventis Product Introduction
7.3.3 Sanofi-Aventis RNA-Based Vaccines Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Profiles
7.4.2 Abbott Laboratories Product Introduction
7.4.3 Abbott Laboratories RNA-Based Vaccines Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Arrowhead Pharmaceuticals
7.5.1 Arrowhead Pharmaceuticals Company Profiles
7.5.2 Arrowhead Pharmaceuticals Product Introduction
7.5.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Benitec Biopharma
7.6.1 Benitec Biopharma Company Profiles
7.6.2 Benitec Biopharma Product Introduction
7.6.3 Benitec Biopharma RNA-Based Vaccines Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Calimmune Inc
7.7.1 Calimmune Inc Company Profiles
7.7.2 Calimmune Inc Product Introduction
7.7.3 Calimmune Inc RNA-Based Vaccines Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Dicerna
7.8.1 Dicerna Company Profiles
7.8.2 Dicerna Product Introduction
7.8.3 Dicerna RNA-Based Vaccines Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Gradalis
7.9.1 Gradalis Company Profiles
7.9.2 Gradalis Product Introduction
7.9.3 Gradalis RNA-Based Vaccines Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Quark
7.10.1 Quark Company Profiles
7.10.2 Quark Product Introduction
7.10.3 Quark RNA-Based Vaccines Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 RXi
7.12 Senesco
7.13 Silence Therapeutics
7.14 Silenseed
7.15 Tekmira
7.16 Alnylam Pharmaceuticals
8 Conclusion


List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global RNA-Based Vaccines Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global RNA-Based Vaccines Sales (K Unit) by Type (2015-2026)
Figure Global RNA-Based Vaccines Sales (K Unit) and Growth Rate (2015-2026)
Figure Global RNA-Based Vaccines Sales Market Share (%) by Type (2019 -2020)
Table Global RNA-Based Vaccines Sales Value (Million USD) by Type (2015-2026)
Figure Global RNA-Based Vaccines Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global RNA-Based Vaccines Sales Value Market Share (%) by Type (2019-2020)
Table Global RNA-Based Vaccines Sales (K Unit) by Application (2015-2026)
Figure China RNA-Based Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table China RNA-Based Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU RNA-Based Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table EU RNA-Based Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America RNA-Based Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table North America RNA-Based Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan RNA-Based Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan RNA-Based Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India RNA-Based Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table India RNA-Based Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia RNA-Based Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia RNA-Based Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America RNA-Based Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table South America RNA-Based Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa RNA-Based Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa RNA-Based Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global RNA-Based Vaccines Capacity (K Units) and Growth Rate (2015-2026)
Figure Global RNA-Based Vaccines Capacity (K Units) and Growth Rate (2015-2026)
Table Global RNA-Based Vaccines Sales (Unit) by Type (2015-2026)
Figure Global RNA-Based Vaccines Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global RNA-Based Vaccines Sales Revenue (Million USD) by Type (2015-2026)
Figure Global RNA-Based Vaccines Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global RNA-Based Vaccines Consumption (Unit) by Application (2015-2026)
Figure Global RNA-Based Vaccines Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global RNA-Based Vaccines Production (K Unite) by Regions (2015-2020)
Table Global RNA-Based Vaccines CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global RNA-Based Vaccines Production Share by Regions (2019-2020)
Table Global RNA-Based Vaccines Sales (K Unite) by Regions (2015-2020)
Table Global RNA-Based Vaccines CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global RNA-Based Vaccines Sales Share by Regions (2019-2020)
Table Global RNA-Based Vaccines Sales Revenue (Million USD) by Regions (2015-2020)
Table Global RNA-Based Vaccines CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global RNA-Based Vaccines Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of RNA-Based Vaccines
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of RNA-Based Vaccines
Figure Cost Structure of RNA-Based Vaccines in 2020
Table Global RNA-Based Vaccines Capacity Share of Manufacturers (2019-2020)
Figure Global RNA-Based Vaccines Capacity Share of Manufacturers (2019-2020)
Table Global RNA-Based Vaccines Sales Market Share of Manufacturers (2019-2020)
Figure Global RNA-Based Vaccines Sales Market Share of Manufacturers (2019-2020)
Table Global RNA-Based Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global RNA-Based Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global RNA-Based Vaccines Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ????Pfizer Profiles
Table ????Pfizer RNA-Based Vaccines Product Introduction
Table ????Pfizer RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Pfizer SWOT Analysis
Table ????Roche Profiles
Table ????Roche RNA-Based Vaccines Product Introduction
Table ????Roche RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Roche SWOT Analysis
Table ????Sanofi-Aventis Profiles
Table ????Sanofi-Aventis RNA-Based Vaccines Product Introduction
Table ????Sanofi-Aventis RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Sanofi-Aventis SWOT Analysis
Table ????Abbott Laboratories Profiles
Table ????Abbott Laboratories RNA-Based Vaccines Product Introduction
Table ????Abbott Laboratories RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Abbott Laboratories SWOT Analysis
Table ????Arrowhead Pharmaceuticals Profiles
Table ????Arrowhead Pharmaceuticals RNA-Based Vaccines Product Introduction
Table ????Arrowhead Pharmaceuticals RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Arrowhead Pharmaceuticals SWOT Analysis
Table ????Benitec Biopharma Profiles
Table ????Benitec Biopharma RNA-Based Vaccines Product Introduction
Table ????Benitec Biopharma RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Benitec Biopharma SWOT Analysis
Table ????Calimmune Inc Profiles
Table ????Calimmune Inc RNA-Based Vaccines Product Introduction
Table ????Calimmune Inc RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Calimmune Inc SWOT Analysis
Table ????Dicerna Profiles
Table ????Dicerna RNA-Based Vaccines Product Introduction
Table ????Dicerna RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Dicerna SWOT Analysis
Table ????Gradalis Profiles
Table ????Gradalis RNA-Based Vaccines Product Introduction
Table ????Gradalis RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Gradalis SWOT Analysis
Table ????Quark Profiles
Table ????Quark RNA-Based Vaccines Product Introduction
Table ????Quark RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Quark SWOT Analysis
Table ????RXi Profiles
Table ????RXi RNA-Based Vaccines Product Introduction
Table ????RXi RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????RXi SWOT Analysis
Table ????Senesco Profiles
Table ????Senesco RNA-Based Vaccines Product Introduction
Table ????Senesco RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Senesco SWOT Analysis
Table ????Silence Therapeutics Profiles
Table ????Silence Therapeutics RNA-Based Vaccines Product Introduction
Table ????Silence Therapeutics RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Silence Therapeutics SWOT Analysis
Table ????Silenseed Profiles
Table ????Silenseed RNA-Based Vaccines Product Introduction
Table ????Silenseed RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Silenseed SWOT Analysis
Table ????Tekmira Profiles
Table ????Tekmira RNA-Based Vaccines Product Introduction
Table ????Tekmira RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Tekmira SWOT Analysis
Table ????Alnylam Pharmaceuticals Profiles
Table ????Alnylam Pharmaceuticals RNA-Based Vaccines Product Introduction
Table ????Alnylam Pharmaceuticals RNA-Based Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Alnylam Pharmaceuticals SWOT Analysis